MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
Open Access
- 3 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0152090
Abstract
Doxorubicin (DOX) is one of the most commonly used anticancer drugs in the treatment of hepatoma. However, acquired drug resistance is one of the major challenges for the chemotherapy. In this study, a down-regulation of miR-122 was observed in doxorubicin-resistant Huh7 (Huh7/R) cells compared with its parental Huh7 cells, suggesting miR-122 is associated with the chemoresistance. Meanwhile, luciferase reporter assay proved that the PKM2 is the target of miR-122, and we reported that the glucose metabolism is significantly up-regulated in Huh7/R cells. Importantly, overexpression of miR-122 in Huh7/R cells reversed the doxorubicin-resistance through the inhibition of PKM2, inducing the apoptosis in doxorubicin-resistant cancer cells. Thus, this study revealed that the dysregulated glucose metabolism contributes to doxorubicin resistance, and the inhibition of glycolysis induced by miR-122 might be a promising therapeutic strategy to overcome doxorubicin resistance in hepatocellular carcinoma.Keywords
Funding Information
- Program of Wenzhou Science and Technology Bureau (Y20150023)
This publication has 40 references indexed in Scilit:
- MicroRNA biogenesis pathways in cancerNature Reviews Cancer, 2015
- miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2Cell Death & Disease, 2015
- Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cellsCancer Cell International, 2014
- Diversifying microRNA sequence and functionNature Reviews Molecular Cell Biology, 2013
- Improved chemotherapy for hepatocellular carcinoma.2012
- Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?Journal of Hepatology, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferationMolecular Cancer, 2011
- MicroRNA control of signal transductionNature Reviews Molecular Cell Biology, 2010
- Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?The Oncologist, 2006